Xcout IntelYpsomed Holding AG
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Subscribe to see Ypsomed Holding AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ypsomed Holding AG at a glance
Ypsomed Holding AG is a medical devices company headquartered in Burgdorf, Switzerland. It is publicly listed (YPSN) with a market capitalisation of $6.6B.
Ypsomed Holding AG competitors
A few of Ypsomed Holding AG's closest competitors — see the full list of competitors and alternatives →
SHL Medical AG designs, develops, and manufactures advanced drug delivery systems, specializing in autoinjectors and pen injectors like the Molly, Maggie, and Quanta series. The company provides end-to-end services including device development, final assembly, labeling, and packaging to help patients independently manage chronic conditions.
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
BD (Becton, Dickinson and Company) is a leading global medical technology company. It focuses on advancing the world of health through the development and manufacturing of medical devices, instrument systems, and reagents.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
MicroTech Medical is a pioneer in the diabetes management medical devices industry, established in 2011 and located in the Hangzhou Future Sci-Tech City. The company specializes in the research, development, and manufacturing of diabetes glucose monitoring and treatment products.
Get Ypsomed Holding AG's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ypsomed Holding AG in Xcout Intel
- The full competitor set, tracking, exports and API access